Mycophenolate Mofetil
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
18
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant
Conditions
Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant
Trial Timeline
Oct 1, 2014 → Sep 1, 2016
NCT ID
NCT03517982About Mycophenolate Mofetil
Mycophenolate Mofetil is a pre-clinical stage product being developed by Hikma Pharmaceuticals for Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant. The current trial status is completed. This product is registered under clinical trial identifier NCT03517982. Target conditions include Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant.
Hype Score Breakdown
Clinical
5
Activity
2
Company
5
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03517982 | Pre-clinical | Completed |
Competing Products
20 competing products in Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant